All terms
Clinical & TrialsClinical Evidence
Composite Endpoint
Single endpoint combining multiple component outcomes (e.g., MACE = death + MI + stroke).
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
Composite endpoints increase event rates and statistical power but require careful component selection, individually adjudicated definitions, and reporting of component breakdowns to avoid overstating treatment effect.What this means in practice
Standard practice in cardiovascular device trials (MACE, MALE, NACE); FDA reviewers focus on whether benefit is consistent across components.Primary references
3 sourcesLink health: 3 verified· last checked 2026-05-09
FDA·2NIH·1
- 1
FDA Composite Endpoints GuidanceVerifiedFDAfda.gov
- 2
FDA - Clinical Trials and Human Subject ProtectionVerifiedFDAfda.gov
- 3
ClinicalTrials.govVerifiedNIHclinicaltrials.gov
Inline markers like [1] jump to the matching reference above.